Skip to main content
. 2020 Nov 3;22(3):354–365. doi: 10.3348/kjr.2020.0973

Table 1. Clinicopathologic Characteristics of 103 Participants with 103 Observations.

Participants n = 103
Mean age 63.1 (21–86)
Sex
 Male:female 81:22:00
Cause of liver diseases
 Hepatitis B virus 67 (65)
 Hepatitis C virus 6 (5.8)
 Alcohol 11 (10.7)
 Others 19 (18.3)
Known cirrhosis 45 (43.7)
Child-Pugh classification
 A 95 (92.2)
 B 8 (7.8)
AFP level (ng/mL)* 8.2 (1.1–7466)
PIVKA (mAU/mL)* 35 (11–43913)
Observations n = 103
Size (mm) 28.2 (11–114)
 10–19 58 (56.3)
 ≥ 20 45 (43.7)
CT/MRI LI-RADS category
 LR-3 5 (4.9)
 LR-4 21 (20.4)
 LR-5 60 (58.3)
 LR-M 17 (16.5)
Final diagnosis
 HCC 79 (76.7)
 Non-HCC malignancy
  cHCC-CC 2 (1.9)
  IHCC 11 (10.6)
  Angiosarcoma 1 (1)
  Metastasis 1 (1)
 Benign
  Dysplastic nodule 3 (2.9)
  Adenoma 2 (1.9)
  Regenerative nodule 1 (1)
  Hemangioma 1 (1)
  Focal nodular hyperplasia 1 (1)
  Organizing hematoma 1 (1)
 Reference standard for diagnosis
  Pathological diagnosis 57 (55.3)
  Noninvasive 45 (43.7)
  Typical image features with more than 1-year stability 1 (1)

*Median value, Only for diagnosing hemangioma that presented peripheral globular enhancement pattern on CT and MRI with stability (> 1-year). AFP = alpha-fetoprotein, cHCC-CC = combined hepatocellular-cholangiocarcinoma, HCC = hepatocellular carcinoma, IHCC = intrahepatic cholangiocarcinoma, LI-RADS = Liver Imaging Reporting and Data System, LR = LI-RADS, PIVKA = protein induced by vitamin K absence or antagonist